Edition:
United States

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

4.24USD
7 Dec 2018
Change (% chg)

$0.04 (+0.95%)
Prev Close
$4.20
Open
$4.19
Day's High
$4.26
Day's Low
$4.15
Volume
14,813
Avg. Vol
15,791
52-wk High
$11.70
52-wk Low
$3.35

Select another date:

Tue, Nov 13 2018

Ex-Merrimack Pharmaceuticals employee gets prison for insider trading

A former Merrimack Pharmaceuticals Inc employee was sentenced on Tuesday to six months in prison after being convicted of participating in an insider trading scheme with a friend at a rival biopharmaceutical company.

Merrimack to scrap development of pancreatic cancer treatment

Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

UPDATE 1-Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would discontinue the development of an experimental treatment for pancreatic cancer after the drug failed to meet the main and secondary goals of a mid-stage trial.

Select another date: